A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma. Salvino MA, Luisi FAV, Pianovski MA, Fagioli F, et al. Br J Haematol 2025 Oct 14. doi: 10.1111/bjh.70207.

Read + Share

Amedeo Smart

Independent Medical Education

Salvino MA, Luisi FAV, Pianovski MA, Fagioli F, et al. A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma. Br J Haematol 2025 Oct 14. doi: 10.1111/bjh.70207.
PMID: 41084939